- Home
- LBRT vs JANX Comparison
LBRT vs JANX Comparison
Compare LBRT & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRT
- JANX
- Stock Information
- Founded
- LBRT 2011
- JANX 2017
- Country
- LBRT United States
- JANX United States
- Employees
- LBRT N/A
- JANX N/A
- Industry
- LBRT Oilfield Services/Equipment
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- LBRT Energy
- JANX Health Care
- Exchange
- LBRT Nasdaq
- JANX Nasdaq
- Market Cap
- LBRT 1.9B
- JANX 1.6B
- IPO Year
- LBRT 2018
- JANX 2021
- Fundamental
- Price
- LBRT $12.08
- JANX $25.56
- Analyst Decision
- LBRT Buy
- JANX Strong Buy
- Analyst Count
- LBRT 10
- JANX 7
- Target Price
- LBRT $18.35
- JANX $94.29
- AVG Volume (30 Days)
- LBRT 3.2M
- JANX 929.3K
- Earning Date
- LBRT 04-16-2025
- JANX 05-08-2025
- Dividend Yield
- LBRT 2.65%
- JANX N/A
- EPS Growth
- LBRT N/A
- JANX N/A
- EPS
- LBRT 1.51
- JANX N/A
- Revenue
- LBRT $4,219,497,000.00
- JANX $9,336,000.00
- Revenue This Year
- LBRT N/A
- JANX N/A
- Revenue Next Year
- LBRT $4.48
- JANX $250.58
- P/E Ratio
- LBRT $7.98
- JANX N/A
- Revenue Growth
- LBRT N/A
- JANX 28.12
- 52 Week Low
- LBRT $9.50
- JANX $22.52
- 52 Week High
- LBRT $24.75
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- LBRT 47.81
- JANX 37.10
- Support Level
- LBRT $11.01
- JANX $24.13
- Resistance Level
- LBRT $12.40
- JANX $33.97
- Average True Range (ATR)
- LBRT 0.51
- JANX 2.01
- MACD
- LBRT 0.14
- JANX -0.61
- Stochastic Oscillator
- LBRT 63.69
- JANX 14.53
About LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.